跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
KETAMINE HAMELN INJECTION 50 MG/ML
Approved
THERAPEUTIC
KETAMINE HAMELN INJECTION 50 MG/ML
SIEGFRIED HAMELN GMBH (GERMANY)
🇸🇬 Health Sciences Authority
Approval Date
Jan 9, 2018
Approval ID
93adf8e3a8501c7f
Company
SIEGFRIED HAMELN GMBH (GERMANY)
Type
Therapeutic
Approval Details
Approval Id
93adf8e3a8501c7f
Drug Name
KETAMINE HAMELN INJECTION 50 MG/ML
Product Name
KETAMINE HAMELN INJECTION 50 MG/ML
Approval Number
SIN15402P
Approval Date
2018-01-09
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAMUSCULAR
Atc Code
N01AX03
Atc Item Name
ketamine
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Ketamine hydrochloride 57.7 mg/ml eqv to Ketamine 50mg/ml
50 MG
Ketamine hydrochloride 57.7 mg/ml eqv to Ketamine 50mg/ml
50 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 9, 2018
Approval ID
93adf8e3a8501c7f
Type
Therapeutic
Back to HSA Approvals
KETAMINE HAMELN INJECTION 50 MG/ML - HSA Drug Approval Details